Document:

EX-10.11

 

Exhibit 10.11

EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT (this “Agreement”) dated as of January 1, 2008 between LEONARD OSSER (the
“Executive”) and MILESTONE SCIENTIFIC INC. (the “Company”).

     WHEREAS, the Company would like to employ the Executive as its Chairman; and

     WHEREAS, the Company and the Executive desire to provide for the terms and conditions of the
future employment of the Executive by the Company.

     NOW, THEREFORE, in consideration of the premises and covenants herein contained, the parties
hereto agree as follows:

     1. New Employment Term and Termination of Existing Employment Term, etc.

     (a) Subject to the terms and conditions hereof, the Company employs the Executive and the
Executive accepts such employment for the period commencing January 1, 2008 and ending December 31,
2012 (the “New Employment Term”), unless the New Employment Term is terminated as provided in
Section 6.

     (b) The existing employment term (the “Existing Employment Term”), pursuant to an Employment
Agreement dated as of December 20, 2003 between the Executive and the Company (the “2003
Agreement”), is hereby terminated as of the close of business on December 31, 2007 and the 2003
Agreement is hereby terminated as of such date (the “Termination Date”). Notwithstanding the
termination of the Existing Employment Term and the 2003 Agreement, the Executive shall be entitled
to all compensatory and other benefits earned by him under the 2003 Agreement prior to the
Termination Date at the expiration of the New Employment Term; provided, however,
that if the Executive is a “specified employee” of the Company within the meaning of Section
409A(a)(2)(B)(i) of the Internal Revenue Code (the “Code”) (or any successor provision), no payment
under this Section 1(b) in connection with the Executive’s termination of employment (other than a
payment of salary through the date of such termination, and payments on account of termination of
employment by reason of death) shall be made until the date which is six (6) months after the date
of the termination of the employment of the Executive (or, if earlier, the date of death of the
Executive); provided further, if the Company determines based upon written advice of counsel that
any such payment if made during the calendar year that includes the termination date would not be
deductible in whole or in part by reason of Code § 162(m), such payment shall be made on January 2
of the following calendar year (or such later date as may be required under the preceding proviso
if the Executive is a “specified employee”).

     2. Duties and Responsibilities. Until December 31, 2012, the Executive shall serve as the
Chairman of the Board of Directors and as an executive officer of the Company. The Executive shall
assist the Company and the Chief Executive Officer of the Company in their (i) management and
oversight of vendors in China and other key vendors, (ii) arranging for and consummating financing
transactions and (iii) conducting investor relations. The Executive shall also oversee ongoing
patent infringement cases in China. The Executive’s duties shall include necessary travel related
to the foregoing. The Executive shall report to, and be subject to, the direction of the Company’s
Board of Directors with such duties and responsibilities as are commensurate with his title and
position. The Executive shall work on a part time basis and shall devote such time, energy and
attention as is necessary to the business of the Company.

     3. Compensation. In payment for services to be rendered by the Executive hereunder, the
Executive shall be entitled to annual Basic Compensation described below less any withholding
required by law.

     (a) The Basic Compensation shall consist of $200,000 per annum, payable one-half in cash in
accordance with the Company’s usual executive compensation arrangements and payable one-half in the
Company’s common stock valued at a closing price of such stock on January 31st of each
year with respect to the then current year. The shares shall be issued to the Executive following
the end of the New Employment Term and in accordance with the requirements of Code §409. The
Executive acknowledges that the shares issuable under this Section 3(a) will be taken by him for
investment and not for distribution thereof and will not be sold or otherwise disposed of in
violation of the Securities Act of 1933 as amended and the rules and regulations promulgated
thereunder.

     (b) If the Company terminates the Executive’s employment hereunder without Cause, other than
due to death or Disability, or if the Executive terminates his employment for “Good Reason” (both
as defined below), the Executive shall be paid in one lump sum payment as soon as practicable
following such termination: (1) an amount equal to the aggregate present value (as determined in
accordance with Section 280G(d)(4) of the Code) of all compensation and any other benefits pursuant
to Section 3 hereof from the effective date of termination hereunder through the remainder of the
New Employment Term; provided, however, in the event the period from the date of Executive’s
termination hereunder through the remainder of the New Employment Term is less than twelve (12)
months, then the Executive shall receive a lump sum payment equal to the sum of the present value
(as determined in accordance with Section 280G(d)(4) of the Code) of (i) the current annual salary
and the value of all other compensation and other

 

 

benefits payable to the Executive annualized for
a twelve (12) month period, and (ii) an amount equal to any bonus that would have
been paid for such period of less than twelve (12) months in accordance with the terms of any
such bonus arrangement between the Executive and the Company. This payment shall be in addition to
and shall not be offset or reduced by (i) any other amounts that have been earned or accrued or
that have otherwise become payable or will become payable to the Executive or his beneficiaries,
but have not been paid by the Company at the time of termination including, without limitation,
salary, bonuses, severance pay, consulting fees, disability benefits, termination benefits,
retirement benefits, life and health insurance benefits or any other compensation or benefit
payment that is part of any previous, current or future contract, plan or agreement, and (ii) any
indemnification payments that may have accrued but not paid or that may thereafter become payable
to the Executive pursuant to the provisions of the Company’s Charter, Bylaws or similar policies,
plans or agreements relating to indemnification of directors and officers of the Company under
certain circumstances.

     (c) If a Change of Control (as defined in Appendix A) occurs during the term of this
Agreement, and:

     (1) the Executive’s employment is terminated involuntarily, or voluntarily by the Executive
based on (i) material changes in the nature or scope of the Executive’s duties or employment, (ii)
a reduction in compensation of the Executive made without the Executive’s consent, or (iii) a
relocation of the Company’s executive offices outside the New York City metropolitan area then the
Executive may, in his sole discretion, give written notice within thirty (30) days after the date
of termination of employment to the Secretary or Assistant Secretary of the Company that he is
exercising his rights hereunder and requests payment of the amounts provided for under this Section
3(c); or

     (2) the Executive gives written notice of his termination of employment for any reason
concurrently with the time a Change of Control occurs or any time within thirty (30) days after the
date the Change of Control becomes effective to the Secretary or Assistant Secretary of the
Company, he may exercise his rights hereunder and request payment of the amounts provided for under
this Section 3(c) (the notice provided pursuant to Subsection (c)(1) or Subsection (c)(2) is
referred to as the “Notice of Exercise”)

and the Executive gives a Notice of Exercise to receive the payments provided for hereunder, the
Company shall pay to or for the benefit of the Executive, immediately upon the Company’s receipt of
the Notice of Exercise, a single cash payment for damages suffered by the Executive by reason of
the Change in Control in the same amount specified in paragraph (b), above. This payment shall be
in addition to and shall not be offset or reduced by (i) any other amounts that have been earned or
accrued or that have otherwise become payable or will become payable to the Executive or his
beneficiaries, but have not been paid by the Company at the time the Executive gives the Notice of
Exercise

     4. Expenses. During the New Employment Term, the Executive shall be entitled to receive
prompt reimbursement, but in no event later than 30 days after submission, for all reasonable
expenses incurred by him (in accordance with the policies and procedures established from time to
time by the Board of Directors of the Company) in performing services hereunder, including, without
limitation, six business trips per year to China by business class air transport, provided that
such expenses are incurred and accounted for in accordance with the policies and procedures
established by the Company.

     5. Other Benefits. The Executive shall be entitled to the following additional benefits:

     (a) Such major medical, and family health coverage benefits and long-term disability group
plan coverage generally available to the Company’s officers. To the extent the Executive
qualifies, the Executive may participate in, or benefit under, any employee benefit plan,
arrangement or perquisite made available by the Company to its key executives.

     (b) Ordinary and necessary business related expenses as shall be incurred by the Executive in
the course of the performance of his duties under this Agreement.

     (c) A monthly car allowance in the amount of the monthly rental cost of a domestic luxury
sedan or its equivalent plus expenses for business use.

     6. Termination. During the New Employment Term, the Executive’s employment hereunder may be
terminated under the following circumstances:

     (a) The Company shall have the right to terminate the employment of the Executive under this
Agreement for disability in the event the Executive suffers an injury, or physical or mental
illness or incapacity of such character as to substantially disable him from performing his duties
hereunder for a period of more than one hundred eighty (180) consecutive days upon the Company
giving at least thirty (30) days written notice of termination; provided, however, that if the
Executive is eligible to receive disability payments pursuant to a disability insurance policy or
policies paid for by the Company, the Executive shall assign such benefits to the Company for all
periods as to which he is receiving payment under this Agreement.

     (b) This Agreement shall terminate upon the death of Executive.

     (c) The Company may terminate this Agreement at any time for “Cause” because of (i) his
becoming the subject of felony criminal charges in the United States or violating such rules and
regulations of the Securities and Exchange Commission as may result in criminal action or material
fines against the Company. (ii) Executive’s material breach of any term of this Agreement or (iii)
the willful engaging by the Executive in misconduct which is materially injurious to the Company,
monetarily or otherwise;

 

 

provided, in the case or (ii) or (iii), however, that the Company shall
not terminate this Agreement pursuant to this Section 6(c) unless
the Company shall first have delivered to the Executive a notice which specifically identifies such
breach or misconduct, specifies reasonable corrective action and the Executive shall not have cured
the breach or corrected the misconduct within thirty (30) days after receipt of such notice.

     (d) The Executive may terminate his employment for “Good Reason” on five days written notice
if:

     (i) he is assigned, without his express written consent, any duties inconsistent with his
positions, duties, responsibilities, authority and status with the Company as of the date hereof,
or a change in his reporting responsibilities or titles as in effect as of the date hereof, except
in connection with the termination of his employment by him without Good Reason; or

     (ii) his compensation is reduced; or

     (iii) any purchaser or purchasers of substantially all of the business or assets of the
Company do not agree, at or prior to the closing of any such transaction, by agreement in form and
substance satisfactory to the Executive to perform this Agreement in the same manner and to the
same extent that the Company would be required to perform if no sale was consummated.

     7. Nondisclosure; Noncompetition.

     (a) The Executive agrees not to use or disclose, either while in the Company’s employ or at
any time thereafter, except with the prior written consent of the Board of Directors, any trade
secrets, proprietary information, or other information that the Company reasonably considers
confidential relating to processes, suppliers (including but not limited to a list or lists of
suppliers), customers (including but not limited to a list or lists of customers), compositions,
improvements, inventions, operations, processing, marketing, distributing, selling, cost and
pricing data, or master files utilized by the Company, not presently generally known to the public,
and which is, obtained or acquired by the Executive while in the employ of the Company.

     (b) During his employment and for a period of two years thereafter, the Executive shall not,
directly or indirectly; (i) in any manner, engage in any business which competes with any business
conducted by the Company (including any subsidiary) and will not directly or indirectly own,
manage, operate, join, control or participate in the ownership, management, operation or control
of, or be employed by or connected in any manner with any corporation, firm or business that is so
engaged (provided, however, that nothing herein shall prohibit the Executive from owning not more
than three percent (3%) of the outstanding stock of any publicly held corporation), (ii) persuade
or attempt to persuade any employee of the Company to leave the employ of the Company or to become
employed by any other entity, or (iii) persuade or attempt to persuade any current client or former
client with leaving, or to reduce the amount of business it does or intends or anticipates doing
with the Company.

     (c) During his employment with the Company, and for two years thereafter, the Executive shall
not take any action which might divert from the Company any opportunity learned about by him during
his employment with the Company (including without limitation during the New Employment Term) which
would be within the scope of any of the businesses then engaged in or planned to be engaged in by
the Company. The parties acknowledge that currently the Company’s business is the delivery of
anesthetics and other medicaments through computer controlled systems.

     (d) In the event that this Agreement shall be terminated, then notwithstanding such
termination, the obligations of the Executive pursuant to this Section 7 of this Agreement shall
survive such termination.

     8. Successors; Binding Agreement.

     (a) The Company shall require any purchaser or purchasers of the Company or any purchaser or
purchasers of substantially all of the business or assets of the Company, by agreement in form and
substance satisfactory to the Executive, to assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it if no such purchase
had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore
defined and any successor to its business or assets which executes and delivers the agreement
provided for in this Section 8(a) or which otherwise becomes bound by all the terms and provisions
of this Agreement by operation of law.

     (b) This agreement shall inure to the benefit of and be enforceable by the Executive’s
personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees. If the Executive should die while any amount would still be payable
hereunder if the Executive had continued to live, all such amounts, unless otherwise provided
herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee,
legatee or other designee or, if there be no such designee, to the Executive’s estate.

     9. Amendment; Waiver. No provisions of this Agreement may be modified, supplemented, waived
or discharged unless such waiver, modification or discharge is agreed to in a writing signed by the
Executive and the Company. No waiver by either party hereto at any time of any breach by the other
party hereto of, or in compliance with, any condition or provision of this Agreement to be
performed by such other party shall be deemed a waiver of similar or dissimilar provisions or
conditions at the same or at any prior or subsequent time. No agreements or representations, oral
or otherwise, express or implied, with respect to the subject matter hereof have been made by
either party which are not set forth expressly in this Agreement.

 

 

     10. Applicable Law. The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of New Jersey without regard to its conflict
of laws principles.

     11. Severability of Covenants. In the event that any provision of this Agreement, including
any sentence, clause or part hereof, shall be deemed contrary to law or invalid or unenforceable in
any respect by a court of competent jurisdiction, the remaining provisions shall not be affected,
but shall remain in full force and effect and any invalid and enforceable provisions shall be
deemed, without further action on the part of the undersigned, modified, amended and limited solely
to the extent necessary to render the same valid and enforceable.

     12. Remedies.

     (a) In the event of a breach or threatened breach of any of the Executive’s covenants under
Section 7, the Executive acknowledges that the Company will not have an adequate remedy at law.
Accordingly, in the event of any such breach or threatened breach, the Company will be entitled to
such equitable and injunctive relief as may be available to restrain the Executive from the
violation of the provisions thereof.

     (b) Nothing herein shall be construed as prohibiting the Company, on the one hand, and the
Executive, on the other hand, from pursuing any remedies available at law or in equity for any
breach or threatened breach of the provisions of this Agreement by the other party, including the
recovery of damages.

     (c) If the Executive terminates his employment for a Good Reason (as defined above in Section
6(d)) then the Executive will suffer damages which will be difficult to calculate. Consequently,
the Executive shall be entitled by way of liquidated damages, and not as a penalty, to receive a
lump sum payment in an amount equal to the amount of the compensation payments that, but for his
termination of employment, would have been payable to the Executive under Section 3(a) for the
remainder of the New Employment Term. Such payment shall be made by the Company to the Executive
within fifteen (15) days following his termination of employment. The Executive shall not be
required to mitigate the amount of any payment received pursuant to this paragraph nor shall the
amount payable under this paragraph be reduced by any compensation earned by the Executive after
the date of his termination of employment.

     13. Notices. Any notice, request, instruction or other document to be given hereunder by any
party to the other party shall be in writing and shall be deemed to have been duly given when
delivered personally or five (5) days after dispatch by registered or certified mail, postage
prepaid, return receipt requested, to the party to whom the same is so given or made:

	 	 	 
	If to the Company
	 	 
	 
	 	 
	addressed to:

	 	Milestone Scientific Inc.
	 

	 	220 South Orange Avenue
	 

	 	Livingston Corporate Park
	 

	 	Livingston, New Jersey 07039
	 
	 	 
	with a copy to:

	 	Morse, Zelnick, Rose & Lander, LLP
	 

	 	405 Park Avenue
	 

	 	New York, New York 10022
	 

	 	Attn: Stephen A. Zelnick, Esq.
	 
	 	 
	If to the Executive
	 	 
	 

	addressed to:

	 	Mr. Leonard Osser
	 

	 	211 East 70th Street
	 

	 	New York, NY 10021

or to such other address as the one party shall specify to the other party in writing.

14. Entire Agreement. This Agreement sets forth the entire agreement of the parties hereto in
respect of the subject matter contained herein and supersedes all prior agreements, promises,
covenants, arrangements, communications, representations or warranties, whether oral or written, by
any officer, employee or representative of any party hereto; and any prior agreement of the parties
hereto in respect of the subject matter contained herein is hereby terminated and canceled.

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above
written.

	 	 	 	 	 
	 	MILESTONE SCIENTIFIC INC.

 	 
	 	By:
	 	/s/ Joe W. Martin
 
	 	 	 	Joe W. Martin 	 
	 	 	 	Chief Executive Officer 	 
	 	 	 
	 	 	 	                           /s/ Leonard Osser
 	 
	 	 	 	Leonard Osser 	 
	 	 	 
	 

Appendix A

A “Change of Control” shall be deemed to have occurred if and when (1) any individual, corporation,
partnership, group, association or other person or entity, together with his, its or their
affiliates or associates (other than a trustee or other fiduciary holding securities under an
employee benefit plan of the Company) hereafter becomes the beneficial owner of securities of the
Company representing thirty percent (30%) or more of the combined voting power of the Company ‘s
then outstanding securities entitled to vote generally in the election of directors; (2) the
continuing directors of the Company shall at any time fail to constitute a majority of the members
of the Board of Directors of the Company; or (3) all or substantially all of the assets of the
Company are sold, conveyed, transferred or otherwise disposed of, whether through one event or a
series of related events, without being approved by the continuing directors of the Company;EX-10.12

 

Exhibit 10.12

EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT dated as of May 2, 2007 between JOE W. MARTIN (the “Executive”) and
MILESTONE SCIENTIFIC INC. (The “Company”).

     WHEREAS, the Company would like to employ the Executive as its Chief Executive Officer; and

     WHEREAS, the Company and the Executive desire to provide for the terms and conditions of the
future employment of the Executive by the Company.

     NOW, THEREFORE, in consideration of the premises and covenants herein contained, the parties
hereto agree as follows:

     1. Initial Term. Subject to the terms and conditions hereof, the Company employs the
Executive and the Executive accepts such employment for the period commencing May 21, 2007 and
ending December 31, 2007 (the “Initial Term”), unless an election is made under Section 2 or the
Initial Term is extended or terminated as provided in Sections 2 and 7, respectively.

     2. Extended Employment Term. The Initial Term shall be extended until December 31, 2012
unless prior to December 31, 2007, either party notifies the other, with or without cause or good
reason, that he or it chooses not to extend the Employment Term.

     3. Duties and Responsibilities. Until December 31, 2007, the Executive shall serve as the
Company’s Chief Executive Officer — Medical. Thereafter, and subject to Section 2, the Executive
shall serve as the Chief Executive Officer of the Company and as the holder of such other senior
executive positions consistent therewith as the Board may determine. He shall report to, and be
subject to, the direction of the Company’s Board of Directors with such duties and responsibilities
as are commensurate with his title and position. The Executive shall work on a full-time basis and
shall devote his time, energy and attention to the business of the Company.

     4. Compensation.

     (a) Basic Compensation. In payment for services to be rendered by the Executive hereunder,
the Executive shall be entitled to annual Basic Compensation consisting of the cash component and
stock component described below less any withholding required by law.

	 	(i)	 	The cash component shall consist of $300,000 per annum, payable
monthly or on such more frequent schedule as the Company may elect, less the
amount, if any, up to $150,000 per year as the Executive by written notice
decides to take in stock for periods subsequent to such notice.
	 
	 	(ii)	 	The stock component shall consist of a stock allotment for the
benefit of the Executive at the end of each calendar year during his employment
(the “Annual Allotment”) consisting of such number of shares of the Company’s
Common Stock (the “Shares”) as provided in (A) below which Shares shall be
issuable as provided in (B) below.

	 	(A)	 	The Annual Allotment for each year shall be such
number of Shares which, when valued at their average closing price on the
American Stock Exchange or on such other market or exchange on which such
Shares are then traded which publish actual closing prices, or at the
average of the closing bid and asked prices in the absence of closing
prices, during the first fifteen (15) trading days of the last full month
of each year during the Executive’s employment, shall equal the amount the
Executive has determined to take in stock as provided in 4(a)(i), provided
that for the Initial Term, and in the event that the last year of the
Executive’s employment is less than twelve (12) full months, the number of
shares included in that year’s Annual Allotment shall be based on the
amount as the Executive has determined, to take in stock as provided in
4(a)(i), multiplied by a fraction the numerator of which shall be the
number of full months the Executive was employed during such year and the
denominator of which shall be twelve (12).
	 
	 	(B)	 	The aggregate number of Shares included in the Annual
Allotments shall be issued and delivered to the Executive within fifteen
(15) days after the expiration the earlier of the Initial Term or the
Extended Employment Term.
	 
	 	(C)	 	The Executive acknowledges that the Shares issuable
under this Section 4(a) and the Bonus Shares issuable under Section 4(b)
will be taken by him for investment and not for distribution thereof and
will not be sold or otherwise disposed of in violation of the Securities
Act of 1933 as amended and the rules and regulations promulgated
thereunder.

     (b) Bonus. The Executive shall be entitled to a bonus of $400,000 each year during his
employment based on the Company achieving certain threshold operating targets established by its
Board of Directors for each calendar year during the Executive’s employment excluding for purposes
of calculation of cash flow and net income the bonuses, if any paid to the current Chief Executive
Officers for 2007. The Executive may also receive such other discretionary bonus amounts as the
Board may determine. For calendar year 2007 the bonus shall be awarded based on meeting the
following thresholds:

 

 

	 	 	 	 	 
	Target	 	Bonus Amount
	The sale of 1,200 STA units
	 	$	100,000	 
	 

	The generation of net revenues of at least $8 million
	 	$	100,000	 
	 

	The achievement of cash flow break-even
	 	$	100,000	 
	 

	The achievement of positive net income
	 	$	100,000	 

     For purposes of this Agreement, operating cash flow shall mean cash flow from operations
adjusted for financial transactions plus accounts receivable increases and less accounts payable
increases. The Cash Flow Bonus and Earnings Bonus shall be payable only to the extent that payment
thereof will not reduce operating cash flow or earnings as the case may be below break even. The
aggregate bonus earned by Executive in any year will be payable one-half (1/2) in cash payable at
the expiration of the year and one-half (1/2) by an allotment of Shares (the “Bonus Shares”)
determined (based on a valuation equal to one-half (1/2) of the Bonus Amount for such year) as
provided in Section 4(a)(ii)(A) at the end of such year and issuable within 15 days after the
expiration of the earlier of the Initial Term or the Extended Employment Term.

     (c) Options. If in any year the Executive receives an allotment of Bonus Shares under Section
4(b) above, he shall also be entitled to receive options to purchase two times the number of Bonus
Shares included in the allotment. The options shall be issued at the same time that the Bonus
Shares are allotted and shall be exercisable at a per share purchase price equal to 100% of fair
market value on the date of grant or 110% of fair market value if the Executive is the owner of 10%
or more of the Company’s outstanding shares. Such options shall have a five (5) year duration and
shall vest and become exercisable to the extent of one-third (1/3) of the options granted at the
expiration of each of the first three (3) years from the date of grant. The vested options shall
be exercisable only while Executive is employed by the Company or within thirty (30) days after any
termination of employment. The options shall contain anti-dilution protection in the event of
stock dividends and splits and such other provisions as are customary in option grants of this
kind.

     5. Expenses. During the Initial Term and the Extended Employment Term, the Executive shall
be entitled to receive prompt reimbursement for all reasonable expenses incurred by him (in
accordance with the policies and procedures established from time to time by the Board of Directors
of the Company) in performing services hereunder, provided that such expenses are incurred and
accounted for in accordance with the policies and procedures established by the Company.

     6. Other Benefits. The Executive shall be entitled to the following additional benefits:

	 	(i)	 	Four weeks of paid vacation during each year of the term following the Initial
Term.
	 
	 	(ii)	 	Paid holidays in accordance with the Company’s usual holiday schedule, plus eight
additional paid holiday, or personal days, to be taken at such time as the Executive
determines.
	 
	 	(iii)	 	Such major medical, and family health coverage benefits and long-term disability
group plan coverage generally available to the Company’s officers. To the extent the
Executive qualifies, the Executive may participate in, or benefit under, any employee
benefit plan, arrangement or perquisite made available by the Company to its key
executives.
	 
	 	(iv)	 	Ordinary and necessary business related expenses as shall be incurred by the
Executive in the course of the performance of his duties under this Agreement.
	 
	 	(v)	 	A monthly car allowance in the amount of $1,000.
	 
	 	(vi)	 	Reasonable and necessary moving expenses to cover relocation to New Jersey.

     7. Termination. Following the Initial Term, the Executive’s employment hereunder may be
terminated under the following circumstances:

     (a) The Company shall have the right to terminate the employment of the Executive under this
Agreement for disability in the event the Executive suffers an injury, or physical or mental
illness or incapacity of such character as to substantially disable him from performing his duties
hereunder for a period of more than one hundred eighty (180) consecutive days upon the Company
giving at least thirty (30) days written notice of termination; provided, however, that if the
Executive is eligible to receive disability payments pursuant to a disability insurance policy or
policies paid for by the Company, the Executive shall assign such benefits to the Company for all
periods as to which he is receiving payment under this Agreement.

     (b) This Agreement shall terminate upon the death of Executive.

     (c) The Company may terminate this Agreement at any time for “Cause” because of (i) his
becoming the subject of criminal charges or violating such rules and regulations of the Securities
and Exchange Commission as may result in criminal action or material fines against the Company.
(ii) Executive’s material breach of any term of this Agreement or (iii) the willful engaging by the
Executive in misconduct which is materially injurious to the Company, monetarily or otherwise;
provided, in the case or (ii) or (iii), however, that the Company shall not terminate this
Agreement pursuant to this Section 7(c) unless the Company shall first have

 

 

delivered to the
Executive a notice which specifically identifies such breach or misconduct, specifies reasonable
corrective action and the Executive shall not have cured the breach or corrected the misconduct
within fifteen (15) days after receipt of such notice.

     (d) The Executive may terminate his employment for “Good Reason” on five days written
notice if:

	 	(i)	 	he is assigned, without his express written consent, any duties
inconsistent with his positions, duties, responsibilities, authority and status
with the Company as of the date hereof, or a change in his reporting
responsibilities or titles as in effect as of the date hereof, except in
connection with the termination of his employment by him without Good Reason; or
	 
	 	(ii)	 	his compensation is reduced or
	 
	 	(iii)	 	any purchaser or purchasers of substantially all of the business
or assets of the Company do not agree, at or prior to the closing of any such
transaction, by agreement in form and substance satisfactory to the Executive to
perform this Agreement in the same manner and to the same extent that the Company
would be required to perform if no sale was consummated.

     8. Nondisclosure; Noncompetition.

     (a) The Executive agrees not to use or disclose, either while in the Company’s employ or at
any time thereafter, except with the prior written consent of the Board of Directors, any trade
secrets, proprietary information, or other information that the Company considers confidential
relating to processes, suppliers (including but not limited to a list or lists of suppliers),
customers (including but not limited to a list or lists of customers), compositions, improvements,
inventions, operations, processing, marketing, distributing, selling, cost and pricing data, or
master files utilized by the Company, not presently generally known to the public, and which is,
obtained or acquired by the Executive while in the employ of the Company.

     (b) During his employment and for a period of two years thereafter, the Executive shall not,
directly or indirectly; (i) in any manner, engage in any business which competes with any business
conducted by the Company (including any subsidiary) and will not directly or indirectly own,
manage, operate, join, control or participate in the ownership, management, operation or control
of, or be employed by or connected in any manner with any corporation, firm or business that is so
engaged (provided, however, that nothing herein shall prohibit the Executive from owning not more
than three percent (3%) of the outstanding stock of any publicly held corporation), (ii) persuade
or attempt to persuade any employee of the Company to leave the employ of the Company or to become
employed by any other entity, or (iii) persuade or attempt to persuade any current client or former
client with leaving, or to reduce the amount of business it does or intends or anticipates doing
with the Company.

     (c) During his employment with the Company, and for two years thereafter, the Executive shall
not take any action which might divert from the Company any opportunity learned about by him during
his employment with the Company (including without limitation during the Initial Term and the
Extended Employment Term) which would be within the scope of any of the businesses then engaged in
or planned to be engaged in by the Company.

     (d) In the event that this Agreement shall be terminated, then notwithstanding such
termination, the obligations of the Executive pursuant to this Section 8 of this Agreement shall
survive such termination.

     9. Successors; Binding Agreement.

     (a) The Company shall require any purchaser or purchasers of the Company or any purchaser or
purchasers of substantially all of the business or assets of the Company, by agreement in form and
substance satisfactory to the Executive, to assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it if no such purchase
had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore
defined and any successor to its business or assets which executes and delivers the agreement
provided for in this Section 9(a) or which otherwise becomes bound by all the terms and provisions
of this Agreement by operation of law.

     (b) This agreement shall inure to the benefit of and be enforceable by the Executive’s
personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees. If the Executive should die while any amount would still be payable
hereunder if the Executive had continued to live, all such amounts, unless otherwise provided
herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee,
legatee or other designee or, if there be no such designee, to the Executive’s estate.

     10. Amendment; Waiver. No provisions of this Agreement may be modified, supplemented, waived
or discharged unless such waiver, modification or discharge is agreed to in a writing signed by the
Executive and the Company. No waiver by either party hereto at any time of any breach by the other
party hereto of, or in compliance with, any condition or provision of this Agreement to be
performed by such other party shall be deemed a waiver of similar or dissimilar provisions or
conditions at the same or at any prior or subsequent time. No agreements or representations, oral
or otherwise, express or implied, with respect to the subject matter hereof have been made by
either party which are not set forth expressly in this Agreement.

     11. Applicable Law. The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of New Jersey without regard to its conflict
of laws principles.

     12. Severability of Covenants. In the event that any provision of this Agreement, including
any sentence, clause or part hereof, shall be deemed contrary to law or invalid or unenforceable in
any respect by a court of competent jurisdiction, the remaining provisions shall not be affected,
but shall remain in full force and effect and any invalid and enforceable provisions shall be
deemed, without further action on the part of the undersigned, modified, amended and limited solely
to the extent necessary to render the same valid and enforceable.

 

 

     13. Remedies.

     (a) In the event of a breach or threatened breach of any of the Executive’s covenants under
Section 8, the Executive acknowledges that the Company will not have an adequate remedy at law.
Accordingly, in the event of any such breach or threatened
breach, the Company will be entitled to such equitable and injunctive relief as may be available to
restrain the Executive from the violation of the provisions thereof.

     (b) Nothing herein shall be construed as prohibiting the Company, on the one hand, and the
Executive, on the other hand, from pursuing any remedies available at law or in equity for any
breach or threatened breach of the provisions of this Agreement by the other party, including the
recovery of damages.

     (c) If the Company terminates this Agreement at any time without Cause (as defined above in
section 7(c)) or the Executive terminates his employment for a Good Reason (as defined above in
Section 7(d)), after January 1, 2008, the Executive shall be entitled under this Section 13(c) to
receive an amount equal to the amount of the compensation payments that, but for his termination of
employment, would have been payable to the Executive under Section 4(a) as follows:

	 	 	 
	Termination under Section 13(c)	 	Compensation under Section 4(a)
	Within the first full calendar year
of the Executive’s employment

	 	an amount equal to the amount of
compensation payments for 4 months
	 
	 	 
	Within the second full calendar year
of the Executive’s employment

	 	an amount equal to the amount of
compensation payments for 12 months
	 
	 	 
	Within or after the third full
calendar year of the Executive’s
employment

	 	an amount equal to the amount of
compensation payments for one 18
months

The Executive shall also be entitled to the amounts of any bonus payments under
§4(b) for the year of termination to the extent that targets were achieved
prior to the date of termination.

     (f) The above amounts shall be deemed liquidated damages, and not a penalty. The Executive
shall not be required to mitigate the amount of any payment received pursuant to this paragraph nor
shall the amount payable under this paragraph be reduced by any compensation earned by the
Executive after the date of his termination of employment.

     14. Notices. Any notice, request, instruction or other document to be given hereunder by any
party to the other party shall be in writing and shall be deemed to have been duly given when
delivered personally or five (5) days after dispatch by registered or certified mail, postage
prepaid, return receipt requested, to the party to whom the same is so given or made:

	 	 	 
	If to the Company
	 	 
	 

	addressed to:

	 	Milestone Scientific Inc.
	 

	 	220 South Orange Avenue
	 

	 	Livingston Corporate Park
	 

	 	Livingston, New Jersey 07039
	 
	 	 
	with a copy to:

	 	Morse, Zelnick, Rose & Lander, LLP
	 

	 	405 Park Avenue
	 

	 	New York, New York 10022
	 
	 	 
	If to the Executive
	 	 
	 

	addressed to:

	 	Mr. Joe W. Martin
	 

	 	2990 Bissonet Street, Apt.# 11201
	 

	 	Houston, TX 77005

or to such other address as the one party shall specify to the other party in writing.

     15. Entire Agreement. This Agreement sets forth the entire agreement of the parties hereto
in respect of the subject matter contained herein and supersedes all prior agreements, promises,
covenants, arrangements, communications, representations or warranties, whether oral or written, by
any officer, employee or representative of any party hereto; and any prior agreement of the parties
hereto in respect of the subject matter contained herein is hereby terminated and canceled.

 

 

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above
written.

	 	 	 	 	 
	 	MILESTONE SCIENTIFIC INC.

 	 
	 	By:  	/s/ Leonard Osser
 	 
	 	 	Leonard Osser, 	 
	 	 	Chairman and Chief Executive Officer 	 
	 
	 	 	 
	 	 	 	                          /s/ Joe W. Martin
 	 
	 	 	 	Joe W. Martin

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]